AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,474,692 | -14.0% | 189,793 | +7.2% | 0.04% | -13.0% |
| Q2 2023 | $1,714,328 | -20.4% | 177,100 | -9.9% | 0.05% | -23.3% |
| Q1 2023 | $2,154,769 | +227.9% | 196,603 | +29.3% | 0.06% | +200.0% |
| Q4 2022 | $657,050 | -53.7% | 152,095 | -19.4% | 0.02% | -60.0% |
| Q3 2022 | $1,419,000 | -44.2% | 188,709 | -25.4% | 0.05% | -42.5% |
| Q2 2022 | $2,542,000 | -18.5% | 252,926 | +0.4% | 0.09% | -5.4% |
| Q1 2022 | $3,119,000 | +103866.7% | 251,976 | +50295.2% | 0.09% | – |
| Q1 2019 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |